[1]
|
吴义波, 吴卓琼, 黄洁丽, 等. 肝动脉灌注化疗对原发性肝癌合并门静脉癌栓的效果[J]. 中国卫生标准管理, 2022, 13(12): 109-112.
|
[2]
|
赵东旭, 张磊, 姜小庆, 等. HAIC是老技术还是新方法——理性看待肝动脉灌注化疗[J]. 介入放射学杂志, 2022, 31(1): 2-8.
|
[3]
|
汪根树. 利用综合治疗措施进一步提高肝癌肝移植疗效[J]. 器官移植, 2021, 12(3): 249-256.
|
[4]
|
Ciria, R., López-Cillero, P., Gallardo, A.B., et al. (2015) Optimizing the Management of Patients with BCLC Stage-B Hepatocellular Carcinoma: Modern Surgical Resection as a Feasible Alternative to Transarterial Chemoembolization. European Journal of Surgical Oncology, 41, 1153-1161. https://doi.org/10.1016/j.ejso.2015.05.023
|
[5]
|
朱广志, 严律南, 彭涛. 中国《原发性肝癌诊疗指南(2022年版)》与《BCLC预后预测和治疗推荐策略(2022年版)》的解读[J]. 中国普外基础与临床杂志, 2022, 29(4): 434-439.
|
[6]
|
Li, Q.-J., et al. (2021) Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 40, 150-160.
|
[7]
|
中国抗癌协会肝癌专业委员会. 肝动脉灌注化疗治疗肝细胞癌中国专家共识(2021版) [J]. 中华消化外科杂志, 2021, 20(7): 754-759.
|
[8]
|
Ikeda, M., Morizane, C., Ueno, M., et al. (2018) Chemotherapy for Hepatocellular Carcinoma: Current Status and Future Perspectives. Japanese Journal of Clinical Oncology, 48, 103-114. https://doi.org/10.1093/jjco/hyx180
|
[9]
|
Ho, W.J., Sharma, G., Zhu, Q., Stein-O’Brien, G., Durham, J., Anders, R., et al. (2020) Integrated Immunological Analysis of a Successful Conversion of Locally Advanced Hepatocellular Carcinoma to Resectability with Neoadjuvant Therapy. The Journal for ImmunoTherapy of Cancer, 8, e000932. https://doi.org/10.1136/jitc-2020-000932
|
[10]
|
Li, Q.J., He, M.K., Chen, H.W., et al. (2022) Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. Journal of Clinical Oncology, 40, 150-160. https://doi.org/10.1200/JCO.21.00608
|
[11]
|
王子卓, 梁斌. 经皮动脉港肝动脉灌注化疗在肝恶性肿瘤中的应用现状和进展[J]. 影像诊断与介入放射学, 2023, 32(4): 290-298.
|
[12]
|
Parks, L. and Villiers, D.A.A. (2022) Use of Hepatic Artery Infusion Pumps in the Treatment of Hepatic Metastases. Clinical Journal of Oncology Nursing, 26, 602-605.
|
[13]
|
Benjamin, T.W., et al. (2022) Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications. Annals of Surgery, 276, 943-956. https://doi.org/10.1097/SLA.0000000000005434
|
[14]
|
陈凛, 张珂诚. 消化道肿瘤完全植入式给药装置临床应用中国专家共识及操作指南(2019版) [J]. 中国实用外科杂志, 2020, 40(2): 152-157. https://doi.org/10.19538/j.cjps.issn1005-2208.2020.02.04
|
[15]
|
Zhao, X., Sun, X., Jing, J., et al. (2021) Safety Study of Folfox-HAIC in Relieving Bed Restriction. Journal of Interventional Medicine, 4, 203-207. https://doi.org/10.1016/j.jimed.2021.10.003
|
[16]
|
Thakor, A.S., Alshammari, M.T., Liu, D.M., et al. (2017) Transradial Access for Interventional Radiology: Single-Centre Procedural and Clinical Outcome Analysis. Canadian Association of Radiologists Journal, 68, 318-327. https://doi.org/10.1016/j.carj.2016.09.003
|
[17]
|
Lyu, N., Lin, Y., Kong, Y., et al. (2018) FOXAI: A Phase II Trial Evaluating the Efficacy and Safety of Hepatic Arterial Infusion of Oxaliplatin plus Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma. Gut, 67, 395-396. https://doi.org/10.1136/gutjnl-2017-314138
|
[18]
|
陈斌, 戴海涛, 林润, 等. 经远桡动脉入路HAIC治疗肝肿瘤的安全性和舒适性研究[J]. 中山大学学报(医学科学版), 2022, 43(4): 639-644.
|
[19]
|
Qin, S., Bai, Y., Lim, H.Y., et al. (2013) Randomized, Multicenter, Open-Label Study of Oxaliplatin plus Fluorouracil/Leucovorin versus Doxorubicin as Palliative Chemotherapy in Patients with Advanced Hepatocellular Carcinoma from Asia. Journal of Clinical Oncology, 31, 3501-3508. https://doi.org/10.1200/JCO.2012.44.5643
|
[20]
|
Ikeda, M., Shimizu, S., Sato, T., et al. (2016) Sorafenib plus Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Advanced Hepatocellular Carcinoma: Randomized Phase II Trial. Annals of Oncology, 27, 2090-2096. https://doi.org/10.1093/annonc/mdw323
|
[21]
|
Hsu, S.J., et al. (2021) Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization. Academic Radiology, 28, S157-S166. https://doi.org/10.1016/j.acra.2021.01.024
|
[22]
|
许书榕, 陈荣新. 肝动脉灌注化疗(HAIC)治疗肝细胞癌(HCC)的研究进展[J]. 复旦学报(医学版), 2019, 46(6): 814-818 823.
|
[23]
|
Seon, D.S., Jun, M.S., Hyun, S.B., et al. (2015) A Comparative Study between Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Gastroenterology, 50, 445-454.
|
[24]
|
Kudo, M., Ueshima, K., Yokosuka, O., et al. (2018) Sorafenib plus Low-Dose Cisplatin and Fluorouracil Hepatic Arterial Infusion Chemotherapy versus Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma (SILIUS): A Randomised, Open Label, Phase 3 Trial. The Lancet Gastroenterology & Hepatology, 3, 424-432. https://doi.org/10.1016/S2468-1253(18)30078-5
|
[25]
|
Issei, S., Takahiro, Y., Masaki, M., et al. (2018) Treatment Strategies for Advanced Hepatocellular Carcinoma: Sorafenib vs Hepatic Arterial Infusion Chemotherapy. World Journal of Hepatology, 10, 571-584. https://doi.org/10.4254/wjh.v10.i9.571
|
[26]
|
Hadjivassiliou, A., Cardarelli-Leite, L., Jalal, S., et al. (2020) Left Distal Transradial Access (ldTRA): A Comparative Assessment of Conventional and Distal Radial Artery Size. CardioVascular and Interventional Radiology, 43, 850-857. https://doi.org/10.1007/s00270-020-02485-7
|
[27]
|
Yamada, R., Bracewell, S., Bassaco, B., et al. (2018) Transradial versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Satisfaction. Journal of Vascular and Interventional Radiology, 29, 38-43. https://doi.org/10.1016/j.jvir.2017.08.024
|
[28]
|
Xu, Y.J., et al. (2021) Toripalimab Combined with Hepatic Arterial Infusion Chemotherapy versus Lenvatinib for Advanced Hepatocellular Carcinoma. Technology in Cancer Research & Treatment, 20. https://doi.org/10.1177/15330338211063848
|
[29]
|
李有赞, 陈凯, 赵冀, 等. 肝动脉灌注化疗联合免疫及靶向治疗不可切除肝癌的临床研究[J]. 实用医院临床杂志, 2022, 19(3): 42-46.
|
[30]
|
岳衍晓, 宁尚昆, 刘吉兵, 等. 晚期原发性肝癌介入治疗与联合靶向药物治疗效果对比分析[J]. 中华肿瘤防治杂志, 2021, 28(10): 788-791. https://doi.org/10.16073/j.cnki.cjcpt.2021.10.13
|
[31]
|
王雅静, 徐竟益, 刘影, 等. FOLFOX-肝动脉灌注化疗联合靶向及免疫治疗巴塞罗那临床肝癌C期肝细胞癌[J]. 中国介入影像与治疗学, 2022, 19(11): 687-692. https://doi.org/10.13929/j.issn.1672-8475.2022.11.004
|